Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating stereotactic body radiation therapy for stage I–II non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: WITHDRAWN